FMO5 and chronic granulomatous disease: In humans, Mendelian defects in MyD88 and CARD9 signaling do not lead to the spontaneous development of aspergillosis, unlike individuals with Mendelian defects in NADPH oxidase activity (i.e. chronic granulomatous disease).